Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Animal models of focal cortical dysplasia and tuberous sclerosis complex: recent progress toward clinical applications Wong MEpilepsia 2009[Oct]; 50 Suppl 9 (0 9): 34-44Focal cortical dysplasia (FCD) and related malformations of cortical development (MCDs) represent an increasingly recognized cause of medically intractable epilepsy. However, the underlying mechanisms of epileptogenesis are poorly understood, and treatments for epilepsy due to various cortical malformations are often limited or ineffective. Animal models offer a number of advantages for investigating cellular and molecular mechanisms of epileptogenesis and developing novel, rational therapies for MCD-related epilepsy. This review highlights specific examples of how animal models have been useful in addressing several clinically relevant issues about epilepsy due to FCDs and related cortical malformations, including the pathologic and clinical features, etiologic factors, localization of the epileptogenic zone, neuronal and astrocytic contributions to epileptogenesis, and the development of antiepileptogenic therapies.|*Disease Models, Animal[MESH]|Animals[MESH]|Anticonvulsants/therapeutic use[MESH]|Cerebral Cortex/pathology/*physiopathology[MESH]|Drug Design[MESH]|Epilepsy/drug therapy/pathology/physiopathology[MESH]|Humans[MESH]|Malformations of Cortical Development/genetics/pathology/*physiopathology[MESH]|Mechanistic Target of Rapamycin Complex 1[MESH]|Mice[MESH]|Mice, Knockout[MESH]|Multiprotein Complexes[MESH]|Proteins[MESH]|Rats[MESH]|Sirolimus/therapeutic use[MESH]|TOR Serine-Threonine Kinases[MESH]|Transcription Factors/genetics[MESH]|Tuberous Sclerosis/genetics/pathology/*physiopathology[MESH] |